Wang K - Search Results

1

Ultrasound-Activated PROTAC Prodrugs Overcome Immunosuppression to Actuate Efficient Deep-Tissue Sono-Immunotherapy in Orthotopic Pancreatic Tumor Mouse Models.

Liu Y, Wang H, Ding M, Yao W, Wang K, Ullah I, Bulatov E, Yuan Y. Liu Y, et al. Among authors: wang h, wang k. Nano Lett. 2024 Jul 17;24(28):8741-8751. doi: 10.1021/acs.nanolett.4c02287. Epub 2024 Jul 2. Nano Lett. 2024. PMID: 38953486

2

Size-Switchable Nanoparticles with Self-Destructive and Tumor Penetration Characteristics for Site-Specific Phototherapy of Cancer.

Wang K, Tu Y, Yao W, Zong Q, Xiao X, Yang RM, Jiang XQ, Yuan Y. Wang K, et al. ACS Appl Mater Interfaces. 2020 Feb 12;12(6):6933-6943. doi: 10.1021/acsami.9b21525. Epub 2020 Feb 3. ACS Appl Mater Interfaces. 2020. PMID: 31951372

3

A General Strategy for Macrotheranostic Prodrug Activation: Synergy between the Acidic Tumor Microenvironment and Bioorthogonal Chemistry.

Dong Y, Tu Y, Wang K, Xu C, Yuan Y, Wang J. Dong Y, et al. Among authors: wang k, wang j. Angew Chem Int Ed Engl. 2020 Apr 27;59(18):7168-7172. doi: 10.1002/anie.201913522. Epub 2020 Mar 6. Angew Chem Int Ed Engl. 2020. PMID: 32003112

4

Intercellular delivery of bioorthogonal chemical receptors for enhanced tumor targeting and penetration.

Tu Y, Dong Y, Wang K, Shen S, Yuan Y, Wang J. Tu Y, et al. Among authors: wang k, wang j. Biomaterials. 2020 Nov;259:120298. doi: 10.1016/j.biomaterials.2020.120298. Epub 2020 Aug 14. Biomaterials. 2020. PMID: 32827798

5

Polyprodrug with glutathione depletion and cascade drug activation for multi-drug resistance reversal.

Xiao X, Wang K, Zong Q, Tu Y, Dong Y, Yuan Y. Xiao X, et al. Among authors: wang k. Biomaterials. 2021 Mar;270:120649. doi: 10.1016/j.biomaterials.2020.120649. Epub 2021 Jan 6. Biomaterials. 2021. PMID: 33588139

6

Amplification of tumor oxidative stresses by Poly(disulfide acetal) for multidrug resistance reversal.

Zong Q, Wang K, Xiao X, Jiang M, Li J, Yuan Y, Wang J. Zong Q, et al. Among authors: wang k, wang j. Biomaterials. 2021 Sep;276:121005. doi: 10.1016/j.biomaterials.2021.121005. Epub 2021 Jul 7. Biomaterials. 2021. PMID: 34252801

7

An NIR-Fluorophore-Based Theranostic for Selective Initiation of Tumor Pyroptosis-Induced Immunotherapy.

Wang K, Xiao X, Jiang M, Li J, Zhou J, Yuan Y. Wang K, et al. Small. 2021 Sep;17(36):e2102610. doi: 10.1002/smll.202102610. Epub 2021 Jul 29. Small. 2021. PMID: 34323375

8

Theranostic Heterodimeric Prodrug with Dual-Channel Fluorescence Turn-On and Dual-Prodrug Activation for Synergistic Cancer Therapy.

Jiang M, Wang K, Xiao X, Zong Q, Zheng R, Yuan Y. Jiang M, et al. Among authors: wang k. Adv Healthc Mater. 2021 Nov;10(21):e2101144. doi: 10.1002/adhm.202101144. Epub 2021 Aug 28. Adv Healthc Mater. 2021. PMID: 34453773

9

Time-programmed activation of dual polyprodrugs for synergistic cascade oxidation-chemotherapy.

Liu Y, Jiang M, Tu Y, Wang K, Zong Q, Yuan Y. Liu Y, et al. Among authors: wang k. Biomaterials. 2021 Nov;278:121136. doi: 10.1016/j.biomaterials.2021.121136. Epub 2021 Sep 20. Biomaterials. 2021. PMID: 34562835

10

Tumor-Acidity and Bioorthogonal Chemistry-Mediated On-Site Size Transformation Clustered Nanosystem to Overcome Hypoxic Resistance and Enhance Chemoimmunotherapy.

Wang K, Jiang M, Zhou J, Liu Y, Zong Q, Yuan Y. Wang K, et al. ACS Nano. 2022 Jan 25;16(1):721-735. doi: 10.1021/acsnano.1c08232. Epub 2022 Jan 3. ACS Nano. 2022. PMID: 34978422

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40,652 results

Search Page

Filters